AGER and Cognitive impairment: Type 2 diabetic patients with mild cognitive impairment have increased serum levels of AGEs and their receptor, RAGE, indicating that the AGE‐RAGE system is a potential contributor to the development of cognitive decline in diabetes (Gorska‐Ciebiada et al., 2015).